Leigh Zawel is Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 69,785 shares of CGEM, which is worth approximately $856,261. The most recent transaction as insider was on Feb 11, 2022, when has been sold 32,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.8K
0% 3M change
0% 12M change
Total Value Held $856,261

Leigh Zawel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2022
BUY
Grant, award, or other acquisition
-
32,500 Added 31.77%
69,785 Common Stock
Oct 15 2021
SELL
Open market or private sale
$489,350 $25.0 p/Share
19,574 Reduced 34.43%
37,285 Common Stock
Oct 07 2021
SELL
Open market or private sale
$26,975 $25.0 p/Share
1,079 Reduced 1.86%
56,859 Common Stock
Sep 20 2021
SELL
Open market or private sale
$187,895 $25.16 p/Share
7,468 Reduced 11.42%
57,938 Common Stock
Sep 07 2021
SELL
Open market or private sale
$814,016 $28.95 p/Share
28,118 Reduced 30.07%
65,406 Common Stock
Aug 23 2021
SELL
Open market or private sale
$815,422 $29.0 p/Share
28,118 Reduced 23.12%
93,524 Common Stock
Aug 10 2021
SELL
Open market or private sale
$189,720 $27.44 p/Share
6,914 Reduced 5.38%
121,642 Common Stock
Aug 09 2021
SELL
Open market or private sale
$568,691 $26.82 p/Share
21,204 Reduced 14.16%
128,556 Common Stock
LZ

Leigh Zawel

Officer
Cambridge, MA

Track Institutional and Insider Activities on CGEM

Follow Cullinan Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

News

Receive news related to Cullinan Oncology, Inc.

Track Activities on CGEM